Accéder au contenu
Merck

[Combination of antimycotic preparations and natural proteinase inhibitors in otomycosis].

Revue de laryngologie - otologie - rhinologie (1993-01-01)
Y A Soushko, O N Borissenko, L I Volosevitch
RÉSUMÉ

In vitro experiments, Terrilytinum* increases the antimycotic activity of Clotrimazolum* and Nitrofungin*, and cancels out the inhibitory effect of Contrycal*. The combined application of Clotrimazolum and Nitrofungin with Terrilytinum and Contrycal as treatment of otomycosis of the middle ear has an outstanding clinical and anti-mycotic efficacy. The results of the investigation show that the proposed method of treatment is marked by an excellent therapeutic efficacy in the case of otomycosis.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2-Chloro-4-nitrophenol, 97%